Document is current

Article History

Accepted: 15 September 2025

First Online: 4 October 2025

Declarations

:

: B.M.K. reports no conflicts of interest. I.D.P. has received speaker's honoraria for speaking at sponsored meetings from Astra Zeneca, Aerocrine, Almirall, Sanofi/Regeneron, Menarini and GSK; and payments for organising educational events from AZ, GSK and Sanofi/Regeneron. He has received honoraria for attending advisory panels with Sanofi/Regeneron, Astra Zeneca, GSK, Merck, Circassia, Chiesi, Upstream Bio and Areteia. He has received sponsorship to attend international scientific meetings from GSK, Astra Zeneca and Sanofi/Regeneron.

: No datasets were generated for this review article. Data discussed in this article can be found in the referenced original studies.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Conceptualisation and planning of the review: B.M.K and I.D.P; writing of the first draft: B.M.K.; critical revision of the manuscript: B.M.K and I.D.P; figures and table: B.M.K and I.D.P. All authors read and approved the final manuscript.